Who is sponsoring NCT05778565?

NCT05778565 is sponsored by Universidad Autonoma de Madrid.

What drugs are being tested in NCT05778565?

Interventions in NCT05778565: Extraocular muscle stretching.

What condition does NCT05778565 study?

NCT05778565 studies Strabismus, Comitant.

Is NCT05778565 still recruiting?

NCT05778565 is currently status unknown. Last updated 3 May 2023.

Last reviewed 2023-05-03 · How we verify

NCT05778565: EOMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extraocular Muscle Stretching as a Weakening Procedure

Status unknown NA Last updated 3 May 2023

What this trial tests

NA trial testing Extraocular muscle stretching in Strabismus, Comitant in 7 participants. Status unknown.

Timeline

13 January 2021

Primary endpoint
23 June 2023

23 June 2023

Quick facts

Lead sponsor	Universidad Autonoma de Madrid
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	7
Start date	13 January 2021
Primary completion	23 June 2023
Estimated completion	23 June 2023
Sites	1 location across Spain

Drugs / interventions tested

Extraocular muscle stretching

Conditions studied

Strabismus, Comitant — all drugs for Strabismus, Comitant →

Sponsor

Universidad Autonoma de Madrid — full company profile →

Who can join

Adults 20 to 60, any sex, with Strabismus, Comitant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interventional case series. Non-operated patients with an indication of medial rectus muscle weakening surgery (deviation up to 20 PD) who could cooperate with topical or sub-Tenon's anesthesia. Clinical workup includes routine complete ophthalmological evaluation. One double needle 6/0 Mersilene suture is used on each side of the muscle at 4 mm distance of the insertion and pulled / stretched to insert in the sclera 3-5 mm posterior to the muscle locking passes. Seven patients with esotropia of 12-20 PD were included.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Extraocular Rectus Muscle Stretching as a Weakening Procedure.
Tejedor J, Gutiérrez-Carmona FJ. · · 2023 · PMID 37392274 · DOI 10.1007/s40123-023-00756-3

Verify or expand the search:

Other Universidad Autonoma de Madrid trials

Trials by the same sponsor.

NCT07090434 — Effect of Bei App for Fibromyalgia · NA · not yet recruiting
NCT06726447 — Artificial Intelligence Satisfaction in Professionals and Patients · NA · recruiting
NCT06601478 — Development and Implementation of a Tool for the Evaluation and Monitoring of the Mediterranean Lifestyle in the Clinica · NA · recruiting
NCT05623579 — Education on BDNF on Pain Levels · NA · unknown
NCT05736172 — 3h of PNE on BDNF and Pain Levels · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05778565 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Madrid
Last refreshed: 3 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05778565.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing